Acting on NCDs: counting the cost

Affiliations

Comment

Tedros Adhanom Ghebreyesus. Lancet. 2018.

. 2018 May 19;391(10134):1973-1974.

doi: 10.1016/S0140-6736(18)30675-5. Epub 2018 Apr 5.

¹ Director General, World Health Organization, 1202 Geneva, Switzerland. Electronic address: DGOffice@who.int.

No abstract available

Comment on

Investing in non-communicable diseases: an estimation of the return on investment for prevention and treatment services.
Bertram MY, Sweeny K, Lauer JA, Chisholm D, Sheehan P, Rasmussen B, Upreti SR, Dixit LP, George K, Deane S. Bertram MY, et al. Lancet. 2018 May 19;391(10134):2071-2078. doi: 10.1016/S0140-6736(18)30665-2. Epub 2018 Apr 5. Lancet. 2018. PMID: 29627159 Review.
Tackling socioeconomic inequalities and non-communicable diseases in low-income and middle-income countries under the Sustainable Development agenda.
Niessen LW, Mohan D, Akuoku JK, Mirelman AJ, Ahmed S, Koehlmoos TP, Trujillo A, Khan J, Peters DH. Niessen LW, et al. Lancet. 2018 May 19;391(10134):2036-2046. doi: 10.1016/S0140-6736(18)30482-3. Epub 2018 Apr 5. Lancet. 2018. PMID: 29627160 Review.